Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adebrelimab”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Testing effectiveness (Phase 2)Looking for participantsNCT06485544
What this trial is testing

Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Who this might be right for
Small Cell Lung Cancer (SCLC)
Tang-Du Hospital 104
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Testing effectiveness (Phase 2)Looking for participantsNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381543
What this trial is testing

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Who this might be right for
Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07112833
What this trial is testing

A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861894
What this trial is testing

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhigang Li 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06452602
What this trial is testing

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07110571
What this trial is testing

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614621
What this trial is testing

Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Fujian Cancer Hospital 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07137039
What this trial is testing

Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen

Who this might be right for
Locally Advanced Hypopharyngeal Cancer
The First Affiliated Hospital of Xiamen University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06474468
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer

Who this might be right for
Advanced or Metastatic Esophageal Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 148
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560
What this trial is testing

Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Harbin Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06620848
What this trial is testing

HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 49
Testing effectiveness (Phase 2)Looking for participantsNCT06885814
What this trial is testing

Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06340230
What this trial is testing

SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer

Who this might be right for
HR Positive/HER2 Low Breast Cancer
Shengjing Hospital 93
Testing effectiveness (Phase 2)Looking for participantsNCT07309185
What this trial is testing

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

Who this might be right for
Stomach Neoplasms
Shandong Tumor Hospital 66
Testing effectiveness (Phase 2)Looking for participantsNCT07141264
What this trial is testing

Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy

Who this might be right for
SCLC,Extensive Stage
Tang-Du Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07241793
What this trial is testing

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

Who this might be right for
Urothelial CarcinomaAdvanced Urothelial CarcinomaUrothelial Carcinoma Recurrent
Sun Yat-sen University 96
Load More Results